当前位置：
X-MOL 学术
›
Circ. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
DNA Methylation Age Mediates Effect of Metabolic Profile on Cardiovascular and General Aging.
Circulation Research ( IF 16.5 ) Pub Date : 2024-09-23 , DOI: 10.1161/circresaha.124.325066 Jiahui Si,Yu Ma,Canqing Yu,Dianjianyi Sun,Yuanjie Pang,Pei Pei,Ling Yang,Iona Y Millwood,Robin G Walters,Yiping Chen,Huaidong Du,Xiaoyan Zheng,Daniel Avery,Junshi Chen,Zhengming Chen,Liming Liang,Liming Li,Jun Lv,
Circulation Research ( IF 16.5 ) Pub Date : 2024-09-23 , DOI: 10.1161/circresaha.124.325066 Jiahui Si,Yu Ma,Canqing Yu,Dianjianyi Sun,Yuanjie Pang,Pei Pei,Ling Yang,Iona Y Millwood,Robin G Walters,Yiping Chen,Huaidong Du,Xiaoyan Zheng,Daniel Avery,Junshi Chen,Zhengming Chen,Liming Liang,Liming Li,Jun Lv,
BACKGROUND
Alterations in lipid metabolism and DNA methylation are 2 hallmarks of aging. Connecting metabolomic, epigenomic, and aging outcomes help unravel the complex mechanisms underlying aging. We aimed to assess whether DNA methylation clocks mediate the association of circulating metabolites with incident atherosclerotic cardiovascular disease (ASCVD) and frailty.
METHODS
The China Kadoorie Biobank is a prospective cohort study with a baseline survey from 2004 to 2008 and a follow-up period until December 31, 2018. We used the Infinium Methylation EPIC BeadChip to measure the methylation levels of 988 participants' baseline blood leukocyte DNA. Metabolite profiles, including lipoprotein particles, lipid constituents, and various circulating metabolites, were measured using quantitative nuclear magnetic resonance. The pace of DNA methylation age acceleration (AA) was calculated using 5 widely used epigenetic clocks (the first generation: Horvath, Hannum, and Li; the second generation: Grim and Pheno). Incident ASCVD was ascertained through linkage with local death and disease registries and national health insurance databases, supplemented by active follow-up. The frailty index was constructed using medical conditions, symptoms, signs, and physical measurements collected at baseline.
RESULTS
A total of 508 incident cases of ASCVD were documented during a median follow-up of 9.5 years. The first generation of epigenetic clocks was associated with the risk of ASCVD (P<0.05). For each SD increment in LiAA, HorvathAA, and HannumAA, the corresponding hazard ratios for ASCVD risk were 1.16 (1.05-1.28), 1.10 (1.00-1.22), and 1.17 (1.04-1.31), respectively. Only LiAA mediated the association of various metabolites (lipids, fatty acids, histidine, and inflammatory biomarkers) with ASCVD, with the mediating proportion reaching up to 15% for the diameter of low-density lipoprotein (P=1.2×10-2). Regarding general aging, a 1-SD increase in GrimAA was associated with an average increase of 0.10 in the frailty index (P=2.0×10-3), and a 33% and 63% increased risk of prefrailty and frailty at baseline (P=1.5×10-2 and 5.8×10-2), respectively; this association was not observed with other clocks. GrimAA mediated the effect of various lipids, fatty acids, glucose, lactate, and inflammatory biomarkers on the frailty index, with the mediating proportion reaching up to 22% for triglycerides in very small-sized very low-density lipoprotein (P=6.0×10-3).
CONCLUSIONS
These findings suggest that epigenomic mechanisms may play a role in the associations between circulating metabolites and the aging process. Different mechanisms underlie the first and second generations of DNA methylation age in cardiovascular and general aging.
更新日期：2024-09-23
京公网安备 11010802027423号